A. Herrick, Vascular function in systemic sclerosis, Current Opinion in Rheumatology, vol.12, issue.6, pp.527-533, 2000.
DOI : 10.1097/00002281-200011000-00009

J. Korn, M. Mayes, M. Cerinic, M. Rainisio, M. Pope et al., Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist, Arthritis & Rheumatism, vol.132, issue.12, pp.3985-3993, 2004.
DOI : 10.1002/art.20676

M. Humbert, E. Segal, D. Kiely, J. Carlsen, and B. Schwierin, Results of European post-marketing surveillance of bosentan in pulmonary hypertension, European Respiratory Journal, vol.30, issue.2, pp.338-344, 2007.
DOI : 10.1183/09031936.00138706

F. Wigley, J. Seibold, R. Wise, D. Mccloskey, and W. Dole, Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis, J Rheumatol, vol.19, pp.1407-1414, 1992.

Y. Kalia, A. Naik, J. Garrison, and R. Guy, Iontophoretic drug delivery, Advanced Drug Delivery Reviews, vol.56, issue.5, pp.619-658, 2004.
DOI : 10.1016/j.addr.2003.10.026

A. Murray, A. Herrick, R. Gorodkin, T. Moore, and T. King, Possible therapeutic use of vasodilator iontophoresis, Microvascular Research, vol.69, issue.1-2, pp.89-94, 2005.
DOI : 10.1016/j.mvr.2005.01.005

A. Murray, T. Moore, T. King, and A. Herrick, Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis?, Rheumatology, vol.47, issue.1, pp.76-79, 2008.
DOI : 10.1093/rheumatology/kem314

S. Blaise, M. Roustit, C. Millet, C. Ribuot, and J. Boutonnat, Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats, British Journal of Pharmacology, vol.19, issue.2, pp.557-565, 2011.
DOI : 10.1111/j.1476-5381.2010.01045.x

S. Fregert, Manual of Contact Dermatitis, 1981.

G. De-nucci, R. Thomas, D. Orleans-juste, P. Antunes, E. Walder et al., Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor., Proceedings of the National Academy of Sciences, vol.85, issue.24, pp.9797-9800, 1988.
DOI : 10.1073/pnas.85.24.9797

J. Cracowski, C. Minson, M. Salvat-melis, and J. Halliwill, Methodological issues in the assessment of skin microvascular endothelial function in humans, Trends in Pharmacological Sciences, vol.27, issue.9, pp.503-508, 2006.
DOI : 10.1016/j.tips.2006.07.008

O. Leary and D. , Regional vascular resistance vs. conductance: which index for baroreflex responses?, Am J Physiol, vol.260, pp.632-637, 1991.

S. Blaise, M. Hellmann, M. Roustit, S. Isnard, and J. Cracowski, Oral sildenafil increases skin hyperaemia induced by iontophoresis of sodium nitroprusside in healthy volunteers, British Journal of Pharmacology, vol.60, issue.5, pp.1128-1134, 2010.
DOI : 10.1111/j.1476-5381.2010.00778.x

N. Dixit, V. Bali, S. Baboota, A. Ahuja, and J. Ali, Iontophoresis -an approach for controlled drug delivery: a review, Curr Drug Deliv, vol.4, pp.1-10, 2007.

E. Rosato, I. Molinaro, F. Borghese, C. Rossi, and S. Pisarri, Bosentan Improves Skin Perfusion of Hands in Patients with Systemic Sclerosis with Pulmonary Arterial Hypertension, The Journal of Rheumatology, vol.37, issue.12, pp.2531-2539, 2010.
DOI : 10.3899/jrheum.100358

M. Hettema, D. Zhang, Y. Stienstra, A. Smit, and H. Bootsma, No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis, Clinical Rheumatology, vol.30, issue.Suppl 1, pp.825-833, 2009.
DOI : 10.1007/s10067-009-1157-4

M. Hettema, D. Zhang, H. Bootsma, and C. Kallenberg, Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis, Annals of the Rheumatic Diseases, vol.66, issue.10, pp.1398-1399, 2007.
DOI : 10.1136/ard.2007.073684

S. Leslie, M. Rahman, M. Denvir, D. Newby, and D. Webb, Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide, British Journal of Clinical Pharmacology, vol.134, issue.6, pp.720-725, 2004.
DOI : 10.1007/s002280050196

E. Lawrence, L. Siney, P. Wilsoncroft, G. Knock, and G. Terenghi, Evidence for ETA and ETB receptors in rat skin and an investigation of their function in the cutaneous microvasculature, British Journal of Pharmacology, vol.175, issue.Suppl. 5, pp.840-844, 1995.
DOI : 10.1111/j.1476-5381.1995.tb15009.x

E. Lawrence and S. Brain, Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin, European Journal of Pharmacology, vol.260, issue.1, pp.103-106, 1994.
DOI : 10.1016/0014-2999(94)90017-5

S. Durand, B. Fromy, P. Bouye, J. Saumet, and P. Abraham, Current-Induced Vasodilation during Water Iontophoresis (5 min, 0.10 mA) Is Delayed from Current Onset and Involves Aspirin Sensitive Mechanisms, Journal of Vascular Research, vol.39, issue.1, pp.59-71, 2002.
DOI : 10.1159/000048994

N. Galie, M. Hoeper, J. Gibbs, and G. Simonneau, Liver toxicity of sitaxentan in pulmonary arterial hypertension, European Respiratory Journal, vol.37, issue.2, pp.475-476, 2011.
DOI : 10.1183/09031936.00194810

S. Blaise, M. Roustit, M. Hellmann, C. Millet, and J. Cracowski, Cathodal Iontophoresis of Treprostinil Induces a Sustained Increase in Cutaneous Blood Flux in Healthy Volunteers, The Journal of Clinical Pharmacology, vol.33, issue.9, 2012.
DOI : 10.1177/0091270011434352

M. Roustit and J. Cracowski, Non-invasive Assessment of Skin Microvascular Function in Humans: An Insight Into Methods, Microcirculation, vol.37, issue.Suppl. 4, pp.47-64, 2012.
DOI : 10.1111/j.1549-8719.2011.00129.x
URL : https://hal.archives-ouvertes.fr/inserm-00767057